CD274 and melanoma: The selected anti-PD-L1-scFv binds to PD-L1 thus interfering in PD-1 and B7.1 interactions, representing the principal PD-L1 receptors on immune cells, and does not interfere with the ability of Ad5Δ24 to induce cell death in an in vitro model of melanoma, actually enhancing it.